A generic alternative indicated for Antivirals. This clinical formulation suppresses the replication of the hepatitis B virus to protect long-term liver health.
Designed to manage chronic Hepatitis B by addressing viral DNA replication to support liver function and mitigate the progression of cirrhosis and cancer.
Mechanism of Action
Entecavir is a powerful antiviral that blocks the enzyme (DNA polymerase) the Hepatitis B virus needs to create copies of its genetic material. This halts the virus's ability to multiply and reduces liver damage.
Route of Administration
Oral
Onset Time
Steady state in 6–10 days
Duration
24 hours
Contraindications
Hypersensitivity to entecavir
Severe Adverse Events
Lactic acidosis, Severe liver enlargement, Hepatitis flare-up after stopping, Kidney impairment
Information for Baraclude is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
